WUHAN, China, March 31, 2021 (GLOBE NEWSWIRE) -- Recently, Aipak Pharma, a global pharmaceutical, food packing and cosmetic equipment supplier, has published a Complete Buying Guide on Capsule Filling ...
Future Market Insights (FMI) projects the global injectable liquid filling machines market is entering a period of steady expansion as pharmaceutical manufacturing advances and the demand for ...
(MENAFN- GlobeNewsWire - Nasdaq) The demand for pharma blister packaging machines is rising due to their ability to protect and extend the shelf life of drugs like tablets and capsules. Key drivers ...
Machine learning for pharma marketers: The time is now to budget, experiment and adjust, expert says
When does CMI/Compas executive Paul Kallukaran think pharma companies should start looking at using machine learning in their marketing strategies? "Yesterday," he said at a recent digital conference.
Fast evolving with time, the Indian pharmaceutical industry is witnessing dynamic changes. Not just the requirements and demands of clients but the ever evolving regulations and new standards of ...
Gujarat’s well-oiled pharmaceutical machinery industry is going full steam ahead. And with Central and state governments also greasing the wheels, this healthcare equipment manufacturing sector will ...
The market is categorized by component into inspection systems and software. The inspection systems segment includes vision inspection systems, X-ray inspection systems, leak detection systems, metal ...
New Delhi, Dec 26 (PTI) As technological advancements like AI, machine learning and precision medicine revolutionise drug discovery, manufacturing and patient care, Indian pharmaceutical industry is ...
Pharm Exec convenes an expert panel at CBI’s Pharmaceutical Compliance Congress to discuss new ways to navigate the many complexities when it comes to the crucial task of assessing business and risk ...
In an interview with Pharm Exec Associate Editor Don Tracy at Financial Times’ US Pharma and Biotech Summit, Tala Fakhouri, Associate Director for Policy Analysis, FDA, discusses the use of artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results